Resiquimod-loaded cationic liposomes cure mice with peritoneal carcinomatosis and induce specific anti-tumor immunity

腹膜腔 免疫系统 医学 癌症研究 CD8型 阳离子脂质体 免疫疗法 免疫学 免疫原性细胞死亡 生物 细胞培养 转染 外科 遗传学
作者
Po‐Han Chao,Vanessa Chan,Jiamin Wu,Lucas J. Andrew,Shyh‐Dar Li
出处
期刊:Journal of Controlled Release [Elsevier BV]
卷期号:372: 362-371 被引量:18
标识
DOI:10.1016/j.jconrel.2024.06.041
摘要

Peritoneal carcinomatosis (PC) is characterized by a high recurrence rate and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), primarily due to incomplete cancer elimination. To enhance the standard of care for PC, we developed two cationic liposomal formulations aimed at localizing a toll-like receptor agonist, resiquimod (R848), in the peritoneal cavity to activate the immune system locally to specifically eradicate residual tumor cells. These formulations effectively extended R848 retention in the peritoneum by >10-fold, resulting in up to a 2-fold increase in interferon α (IFN-α) induction in the peritoneal fluid, without increasing the plasma levels. In a CT26 colon cancer model with peritoneal metastases, these liposomal R848 formulations, when combined with oxaliplatin (OXA)-an agent used in HIPEC that induces immunogenic cell death-increased tumor infiltration of effector immune cells, including DCs, CD4, and CD8 T cells. This led to the complete elimination of PC in 60-70% of the mice, while the control mice reached humane endpoints by 30 days. The cured mice developed specific antitumor immunity, as re-challenging them with the same tumor cells did not result in tumor establishment. However, inoculation with a different tumor line led to tumor development. Additionally, exposing CT26 tumor antigens to the splenocytes isolated from the cured mice induced the expansion of CD4 and CD8 T cells and the release of IFN-γ, demonstrating long-term immune memory to the specific tumor. The anti-tumor efficacy of these liposomal R848 formulations was mediated via CD8 T cells with different levels of involvement of CD4 and B cells, and the combination with an anti-PD-1 antibody achieved a cure rate of 90%.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Heng发布了新的文献求助10
刚刚
xiaokai完成签到,获得积分20
刚刚
1秒前
一位名圆完成签到,获得积分10
1秒前
Lin发布了新的文献求助10
3秒前
思源的应助被可爱如音采纳,获得10
3秒前
maxiaole的应助被麦格布丁采纳,获得10
5秒前
Gogo完成签到 ,获得积分10
5秒前
6秒前
科研通AI6.4的应助被baby采纳,获得10
7秒前
CodeCraft的应助被贾千兰采纳,获得10
7秒前
7秒前
9秒前
隐形曼青的应助被哭泣嵩采纳,获得10
9秒前
9秒前
bkagyin的应助被lcf采纳,获得10
10秒前
11秒前
波爷完成签到,获得积分10
11秒前
11秒前
高高的故事完成签到,获得积分10
11秒前
12秒前
ffff发布了新的文献求助10
12秒前
jikang完成签到,获得积分10
12秒前
13秒前
13秒前
13秒前
爱笑如凡完成签到,获得积分10
14秒前
栀禾完成签到,获得积分10
14秒前
14秒前
14秒前
15秒前
weifengzhong发布了新的文献求助10
15秒前
16秒前
MARK11发布了新的文献求助10
17秒前
默默的香菇完成签到,获得积分10
18秒前
星辰大海的应助被芳芳呐采纳,获得10
18秒前
博修发布了新的文献求助10
18秒前
18秒前
18秒前
ewmmel发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153668
求助须知:如何正确求助?哪些是违规求助? 9550448
关于积分的说明 21698499
捐赠科研通 7742484
什么是DOI,文献DOI怎么找? 3425564
关于科研通互助平台的介绍 2550698
邀请新用户注册赠送积分活动 2469211